Skip to main content
Markkula Center for Applied Ethics


Opinion: The Case for the J&J COVID Vaccine in the Herd-immunity Quest

Margaret McLean, associate director, co-authored an op-ed published by The Mercury News.

In this article, co-authored by Margaret McLean, associate director at the Markkula Center for Applied Ethics, the effectiveness of the Johnson & Johnson vaccine for effectively preventing severe disease and death is celebrated.

"If we consider the primary objective of COVID-19 vaccination to be preventing severe illness and death, the J&J vaccine was as potent as the mRNA vaccines. No one who received the J&J, Moderna or Pfizer vaccines died of COVID-19 during the clinical trials, and very few were even hospitalized. That’s incredibly effective! And evidence is building that these vaccines will offer at least some level of protection against the current crop of variant viruses."

Margaret McLean, associate director, co-authored an op-ed published by The Mercury News.


David Zalubowski/AP Photo